Literature DB >> 10970818

Enhanced expression of the leukotriene C(4) synthase due to overactive transcription of an allelic variant associated with aspirin-intolerant asthma.

M Sanak1, M Pierzchalska, S Bazan-Socha, A Szczeklik.   

Abstract

Aspirin-intolerant asthma (AIA), a distinct clinical syndrome affecting about 10% of adult asthmatics, appears to be unusually dependent on cysteine leukotriene (cys-LT) overproduction by pulmonary eosinophils. The gene coding for leukotriene (LT) C(4) synthase (LTC(4)S), the enzyme controlling cys-LT biosynthesis, exists as two common alleles distinguished by an A to C transversion at a site 444 nucleotides upstream of the translation start. We tested the hypothesis that this single nucleotide polymorphism (SNP) affects binding of transcription factors and influences the transcription rate, predisposing to AIA. Gel shift assay studies revealed that the (-444)C allele, conferring an activator protein-2 binding sequence, is an additional target for a transcription factor of histone H4 consensus. Introduction of the H4TF-2 decoy oligonucleotide into LTC(4)S-positive, differentiated HL-60 cells decreased accumulation of LTC(4) to 68%. Transfection of COS-7 with promoter construct increased expression of beta-galactosidase reporter for the (-444)C variant. The (-444)C allelic frequency was significantly higher in AIA patients (n = 76) as compared with matched aspirin-tolerant asthmatics (n = 110) and healthy controls (n = 75). Patients with AIA had also upregulated LTC(4)S messenger RNA expression in peripheral blood eosinophils. An inhaled provocation test with lysine-aspirin led to an increase in urinary output of LTE(4), which reached statistical significance only in carriers of the (-444)C allele. Our results suggest that a transcription factor, present in dividing and bone marrow resident progenitors of eosinophils, triggers LTC(4)S transcription in carriers of a common (-444)C allele due to binding with the histone H4 promoter element of the gene. Genetic predisposition to cys-LT pathway upregulation, a hallmark of AIA, can be related to overactive expression of the LTC(4)S (-444)C allele.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10970818     DOI: 10.1165/ajrcmb.23.3.4051

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  42 in total

Review 1.  Understanding genomics: implications for the emergency medicine physician and the treatment of asthma.

Authors:  Robert J Freishtat; Stephen J Teach
Journal:  Pediatr Emerg Care       Date:  2006-01       Impact factor: 1.454

Review 2.  Asthma from a pharmacogenomic point of view.

Authors:  C Szalai; I Ungvári; L Pelyhe; G Tölgyesi; A Falus
Journal:  Br J Pharmacol       Date:  2008-03-03       Impact factor: 8.739

3.  Influence of leukotriene pathway polymorphisms on response to montelukast in asthma.

Authors:  John J Lima; Shu Zhang; Audrey Grant; Lianhe Shao; Kelan G Tantisira; Hooman Allayee; Jianwei Wang; James Sylvester; Janet Holbrook; Robert Wise; Scott T Weiss; Kathleen Barnes
Journal:  Am J Respir Crit Care Med       Date:  2005-11-17       Impact factor: 21.405

Review 4.  Sumatriptan-naproxen fixed combination for acute treatment of migraine: a critical appraisal.

Authors:  Chaouki K Khoury; James R Couch
Journal:  Drug Des Devel Ther       Date:  2010-02-18       Impact factor: 4.162

5.  Leukotriene-related gene polymorphisms in patients with aspirin-intolerant urticaria and aspirin-intolerant asthma: differing contributions of ALOX5 polymorphism in Korean population.

Authors:  Seung-Hyun Kim; Jeong-Hee Choi; J W Holloway; Chang-Hee Suh; Dong-Ho Nahm; Eun-Ho Ha; Choon-Sik Park; Hae-Sim Park
Journal:  J Korean Med Sci       Date:  2005-12       Impact factor: 2.153

6.  Nonsteroidal anti-inflammatory drug hypersensitivity in preschool children.

Authors:  Mona Iancovici Kidon; Liew Woei Kang; Chiang Wen Chin; Lim Siok Hoon; Van Bever Hugo
Journal:  Allergy Asthma Clin Immunol       Date:  2007-12-15       Impact factor: 3.406

7.  Role of genetic polymorphisms in therapeutic response to anti-asthma therapy.

Authors:  John Oppenheimer
Journal:  Allergy Asthma Clin Immunol       Date:  2007-06-15       Impact factor: 3.406

8.  Aspirin-exacerbated asthma.

Authors:  Mathew Varghese; Richard F Lockey
Journal:  Allergy Asthma Clin Immunol       Date:  2008-06-15       Impact factor: 3.406

9.  Allelic association and functional studies of promoter polymorphism in the leukotriene C4 synthase gene (LTC4S) in asthma.

Authors:  I Sayers; S Barton; S Rorke; B Beghé; B Hayward; P Van Eerdewegh; T Keith; J B Clough; S Ye; J W Holloway; A P Sampson; S T Holgate
Journal:  Thorax       Date:  2003-05       Impact factor: 9.139

Review 10.  Update on recent advances in the management of aspirin exacerbated respiratory disease.

Authors:  Nami Shrestha Palikhe; Joo-Hee Kim; Hae-Sim Park
Journal:  Yonsei Med J       Date:  2009-12-18       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.